Nitrofurantoin-induced immune-mediated lung and liver disease
Introduction. Nitrofurantoin, a furan derivative, introduced in the fifties has widely been used as an effective agent for the treatment and prevention of urinary tract infections (UTI). Spectrum of adverse reactions to nitrofurantoin is wide, ranging from eosinophilic interstitial lung disease,...
Main Authors: | Milić Rade, Plavec Goran, Tufegdžić Ivana, Tomić Ilija, Šarac Sanja, Lončarević Olivera |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2012-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501206536M.pdf |
Similar Items
-
Nitrofurantoin-induced lung- and hepatotoxicity
by: Anastasios Koulaouzidis;, et al.
Published: (2007-04-01) -
Reintroduction of nitrofurantoin in the treatment of uncomplicated urinary tract infection
by: Sabiha Mahboob, et al.
Published: (2021-07-01) -
Consider Nitrofurantoin as a Cause of Lung Injury
by: Paulo Almeida, et al.
Published: (2019-10-01) -
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease
by: Andreia Carvalho de Matos, et al.
Published: (2021-06-01) -
Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient
by: Lauren L. Rego, et al.
Published: (2016-12-01)